{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:22:04Z","timestamp":1774696924666,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":557,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jacep.2016.01.015","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T19:41:05Z","timestamp":1460144465000},"page":"518-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patient Activity Decreases and Mortality Increases After the Onset of Persistent Atrial Fibrillation in Patients With Implantable Cardioverter-Defibrillators"],"prefix":"10.1016","volume":"2","author":[{"given":"Mihail G.","family":"Chelu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Gunderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel F.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2016.01.015_bib1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2016.01.015_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCOUTCOMES.110.958165","article-title":"Estimation of total incremental health care costs in patients with atrial fibrillation in the United States","volume":"4","author":"Kim","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacep.2016.01.015_bib3","first-page":"e28","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2016.01.015_bib4","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1540-8159.2006.00489.x","article-title":"Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data","volume":"29","author":"Botto","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2016.01.015_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.CIR.101.8.878","article-title":"Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators","volume":"101","author":"Swerdlow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2016.01.015_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCEP.113.001212","article-title":"The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality","volume":"7","author":"Ousdigian","year":"2014","journal-title":"Circulation Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2016.01.015_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2016.01.015_bib8","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2016.01.015_bib9","first-page":"47","article-title":"Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management","volume":"27","author":"Gillis","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacep.2016.01.015_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.hrthm.2011.12.016","volume":"9","author":"Calkins","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2016.01.015_bib11","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1161\/01.CIR.0000139841.42454.78","article-title":"Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device","volume":"110","author":"Adamson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2016.01.015_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/europace\/euu305","article-title":"Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC study","volume":"17","author":"Sears","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2016.01.015_bib13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijcard.2012.11.050","article-title":"Validity of cardiac implantable electronic devices in assessing daily physical activity","volume":"168","author":"Pressler","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2016.01.015_bib14","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jacc.2012.12.014","volume":"61","author":"Epstein","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2016.01.015_bib15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jce.12467","article-title":"Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival","volume":"25","author":"Mohanty","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2016.01.015_bib16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/2047487314538855","article-title":"Health-related quality of life in atrial fibrillation patients over 65 years: a review","volume":"22","author":"Zhang","year":"2015","journal-title":"Eur J Prevent Cardiol"},{"key":"10.1016\/j.jacep.2016.01.015_bib17","first-page":"690","article-title":"Minimally symptomatic atrial fibrillation patients derive significant symptom relief following rate control or rhythm control therapy","volume":"7","author":"King","year":"2015","journal-title":"J\u00a0Clin Med Res"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X16000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X16000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:22:46Z","timestamp":1762500166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X16000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S2405500X16000645"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2016.01.015","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Activity Decreases and Mortality Increases After the Onset of Persistent Atrial Fibrillation in Patients With Implantable Cardioverter-Defibrillators","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2016.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation. Published by Elsevier","name":"copyright","label":"Copyright"}]}}